A metastatic breast cancer drug, discovered in the McDonnell Lab, is now FDA-approved—the first new oral endocrine therapy in 20+ years. Another might not be so far behind.
The hybrid retreat showcased the latest gastric cancer, blood cancer, pediatric sarcoma, glioblastoma, breast cancer, and immune micro-environment research.
"What's Best For Breasts? A Conversation with Clinicians" was held online, Oct. 8. Topics included imaging, genetic testing, breast cancer risk, research, survivorship, and more.
John Wayne Cancer Foundation is funding research by breast surgical oncologist Maggie DiNome, MD, to create a molecular-based way to predict cancer spread to lymph nodes.
DCI study led by Gayathri Devi, PhD, finds chronic stresses such as racism and poverty alter cellular functions that promote tumor growth and proliferation
Donald McDonnell, PhD, associate director for Translational Research, DCI, receives prestigious St. Patrick's Day Irish science medal for contributions to academia and industry.
Susan Dent, MD, FRCPC, associate director, Clinical Research, DCI Breast Cancer Disease Group, has joined the Duke IBC Consortium as clinical director.
The grandfather of breast surgical oncologist Hannah Woriax, MD, was the first Native American to graduate from the Duke Med School and train in Family Medicine.
On Feb. 2 at noon, the Southeastern American Indian Cancer Health Equity Partnership hosts DCI breast surgeon Hannah Woriax, MD, for a virtual lecture (with CME credit available).
Former Blue Devil Maggie DiNome, MD, a breast surgical oncologist, joined Duke from UCLA as medical director of Wake County Breast Cancer Services and as a professor of Surgery.
The metastatic breast cancer research grants, made possible by Susan G. Komen, bring together patient advocates and DCI & UNC Lineberger investigators.
"What's Best For Breasts? A Conversation with Duke Clinicians" was held online on Oct. 2. Topics included imaging, genetic testing, breast cancer risk assessment & prevention.
This OHE-hosted talk featured director of the Patierno/George/Freedman Lab Jennifer Freedman, PhD, and postdocs Tyler Allen, PhD, and Sean Piwarski, PhD.
The 2021 (virtual) Triangle Race for the Cure, presented by DCI, will be held on May 1, but there are many fun activities to try in April to support the cause.
Susan Dent, MD, co-director of the Duke Cardio-Oncology Program, is a leading international expert in the field. She is also associate director of Clinical Research in DCI's Breast Program.
You can count on one hand the number of times a young graduate student finds a drug, then the drug is patented, licensed, and in a phase 2 trial within a couple years.
The American Cancer Society has a long history of awarding grants to DCI researchers as they work to better understand the complexities of cancer and develop new treatments.
Carey Anders, MD, and immunology researchers Erika Crosby, PhD, Zachary Hartman, PhD, among featured speakers at the national Komen MBC webinar series.
Katrina Cooke has beaten the odds; surviving nearly nine years with metastatic breast cancer. Giving of her time to make things better for others has been her lifeline.
Donald McDonnell, PhD, has been recognized for his leadership in estrogen receptor biology by Susan G. Komen with a Brinker Award for Scientific Distinction in Basic Science.
Join Team DCI and turn your miles walked into dollars raised throughout the month of October, then join the virtual National Celebration on October 18.
Komen NCTC hosts its first annual gala to support metastatic breast cancer research; a virtual event with speakers, auctions, and treats on Saturday, October 10, at 7 p.m.
A new approach to training computational models on biological processes provides insights into how and why cancer cells metastasize to certain areas of the vasculature.
A vaccine for HER2-positive breast cancers that is being tested in a clinical trial at DCI is part of an effective, two-drug strategy for enlisting the immune system to fight tumors.